A.   Upper thigh

B.   Upper arm

C.   Forearm

D.   Lower leg

A.   A patient who has stopped taking a beta blocker because of cost

B.   A patient who is taking a beta blocker and furosemide

C.   A patient who is on a beta blocker and a thiazide diuretic

D.   A patient who has been on beta blockers for 1 day

A.   Evaluate the electrocardiogram. Perform a neurologic assessment. Assess oxygenation and ventilation. Obtain an intravenous infusion pump.

B.   Draw baseline serum electrolyte levels. Evaluate the electrocardiogram. Perform a neurologic assessment. Assess the patient for peripheral edema.

C.   Assess oxygenation and ventilation. Obtain an intravenous infusion pump. Draw baseline serum electrolyte levels. Assess the patient for peripheral edema.

D.   Perform a neurologic assessment. Assess oxygenation and ventilation. Draw baseline serum electrolyte levels. Assess the patient for peripheral edema.

A.   Systolic pressure consistently above 140 mm Hg

B.   Diastolic pressure of 70 mm Hg

C.   Diastolic blood pressure of 80 mm Hg after exercise

D.   Blood pressure of 140/90 mm Hg after walking up two flights of stairs

A.   "This type of hypertension is not treatable."

B.   "This type of hypertension has a definitive cause."

C.   "The cause of your hypertension is unknown but treatable."

D.   "Once you have surgery, this will go away."

A.   Reducing heart failure

B.   Promoting cardiovascular health

C.   Increasing life span of population

D.   Reducing renal morbidity and mortality

A.   Dihydropyridines

B.   Benzothiazepines

C.   Aliskiren

D.   Phenylalkylamines

A.   Doxazosin

B.   Carvedilol

C.   Clonidine

D.   Terazosin

A.   Soft drinks

B.   Laxative

C.   Milk

D.   Alcohol

A.   Prazosin (Minipress)

B.   Terazosin (Hytrin)

C.   Doxazosin (Cardura)

D.   Tamsulosin (Flomax)

A.   Doxazosin

B.   Nebivolol

C.   Carvedilol

D.   Clonidine

A.   Decrease in platelet aggregation

B.   Bradycardia

C.   Rash

D.   Hypotension

A.   Treprostinil

B.   Ambrisentan

C.   Sildenafil

D.   Epoprostenol

A.   "Don’t worry. Eventually, tolerance will develop."

B.   "The health care provider can work with you on changing the dose or medication."

C.   "This is an unusual occurrence, but it is important to stay on your medication."

D.   "Sexual dysfunction happens with this therapy, and you will learn to accept it."

A.   "CCBs relax vascular smooth muscle."

B.   "CCBs block reabsorption of sodium."

C.   "CCBs increase blood return to heart."

D.   "CCBs promote excretion of water."

A.   Decreased effect of the nonsteroidal anti-inflammatory drug

B.   Decreased effect of the angiotensin II receptor–blocker drug

C.   Increased effect of the angiotensin II receptor–blocker drug

D.   Increased effect of the nonsteroidal anti-inflammatory drug

A.   Decreased effect of the rifampin

B.   Increased effect of the rifampin

C.   Decreased effect of the angiotensin II receptor–blocker drug

D.   Increased effect of the angiotensin II receptor blocker drug

A.   Furosemide

B.   Metoprolol

C.   Valsartan

D.   Enalapril

A.   Monitor serum calcium and sodium levels daily.

B.   Schedule the dose to be taken in the evening.

C.   Take the radial pulse for 1 full minute before administering the drug.

D.   Encourage intake of foods rich in potassium.

A.   Syncope

B.   Vomiting

C.   Rash

D.   Anorexia

A.   "Take the medication on an empty stomach."

B.   "Remove the old patch before applying the new patch."

C.   "Stay in bed for at least an hour after receiving a new patch."

D.   "Keep the new patch on for 30 minutes before removing the old patch."

A.   Respiratory assessment

B.   Teaching about potential tachycardia

C.   Orthostatic blood pressure assessment

D.   Assessment of blood glucose levels

A.   Potassium-sparing

B.   Thiazide

C.   Osmotic

D.   Loop

A.   "This medication will help your body to get rid of sodium."

B.   "This medication will vasodilate your blood vessels to lower your blood pressure."

C.   "This medication will help you to lose weight to lower your blood pressure."

D.   "This medication will work to cause your body to get rid of fluid."

A.   Decreased cardiac output

B.   Increased urinary output

C.   Tachycardia

D.   Tachypnea

A.   Heart rate of 40 beats/min

B.   Temperature of 38°C (100.4°F)

C.   Respiratory rate of 20 breaths/min

D.   Blood pressure of 110/70 mm Hg

A.   Treprostinil

B.   Eplerenone

C.   Sodium nitroprusside

D.   Losartan

A.   Instruct the patient to take antitussive medication until the symptoms subside.

B.   Consult with the health care provider to switch the medication.

C.   Assess the patient for other symptoms of upper respiratory infection.

D.   Tell the patient that the cough will subside in a few days.

A.   Vomiting and diarrhea, Difficulty ambulating to the bathroom, Disorientation to person, place, and time

B.   Constipation, Difficulty ambulating to the bathroom, Disorientation to person, place, and time

C.   Constipation, Difficulty ambulating to the bathroom, Dizziness,

D.   Dizziness, Headache, Vomiting and diarrhea

A.   Calcium level of 8 mEq/dL

B.   Blood pressure of 80/60 mm Hg

C.   Apical pulse of 100 beats/min

D.   Potassium level of 5 mEq/dL

A.   Dry, nonproductive cough

B.   Angioedema

C.   Fatigue

D.   Diarrhea

A.   Enalapril

B.   Doxazosin

C.   Furosemide

D.   Hydralazine

A.   Heart failure, Diabetes, Emphysema

B.   Cardiovascular disease, Diabetes, Emphysema

C.   Diabetes, Emphysema, Stroke

D.   Stroke, Heart failure, Cardiovascular disease

A.   15.0 mg/day

B.   16.5 mg/day

C.   12.5 mg/day

D.   10.5 mg/day

A.   Candesartan

B.   Felodipine

C.   Propranolol

D.   Hydrochlorothiazide

A.   Persistent dry mouth

B.   Serum sodium of 147 mEq/L

C.   Serum potassium of 4.2 mEq/L

D.   A dry, hacking cough

A.   Hold the medication.

B.   Call the health care provider.

C.   Weigh the patient.

D.   Determine the patient’s history.

A.   "I will check my blood pressure daily and take my medication when it is over 140/90 mm Hg."

B.   "I will include rest periods during the day to help me tolerate the fatigue my medicine may cause."

C.   "I will change my position slowly to prevent feeling dizzy."

D.   "I will not mow my lawn until I see how this medication makes me feel."

A.   Losartan

B.   Enalapril

C.   Ramipril

D.   Captopril

A.   Toxic level of lithium

B.   Toxic level of the ACE inhibitor

C.   Decreased level of lithium

D.   Decreased level of the ACE inhibitor

A.   Restrict dietary fiber intake. Limit fluids to 1000 mL/day. Increase the amount of fruits and vegetables in the diet.

B.   Restrict dietary fiber intake. Inform the patient that this is a common side effect of the medication. Limit fluids to 1000 mL/day.

C.   Discuss incorporation of psyllium-based products in the plan of care with the health care provider. Restrict dietary fiber intake. Limit fluids to 1000 mL/day.

D.   Increase the amount of fruits and vegetables in the diet. Inform the patient that this is a common side effect of the medication. Discuss incorporation of psyllium-based products in the plan of care with the health care provider.

A.   Hemoglobin and hematocrit levels

B.   12-Lead electrocardiogram (ECG)

C.   Serum cyanide level

D.   Fasting blood glucose level

A.   Intravenous fluids

B.   Antianxiety medication

C.   Calcium chloride

D.   Potassium supplements

A.   Peripheral pulses

B.   Serum potassium

C.   Breath sounds

D.   Mental status

A.   Sodium nitroprusside

B.   Bosentan

C.   Treprostinil

D.   Eplerenone

A.   Administer aspirin.

B.   Insert a Foley catheter.

C.   Administer potassium chloride intravenously.

D.   Send the patient for hemodialysis.

A.   "Angiotensin II is a potent vasodilator." "They promote sodium and water retention."

B.   "They promote sodium and water retention." "ACE inhibitors modify the function of the sympathetic nervous system (SNS)."

C.   "ACE inhibitors modify the function of the sympathetic nervous system (SNS)." "Angiotensin II is a potent vasodilator."

D.   "They reduce afterload." "Systemic vascular resistance (SVR) is decreased."

A.   Collaborate with the health care provider to find a combination ACE inhibitor and diuretic.

B.   Instruct the patient to weigh daily.

C.   Ask the patient to perform a 24-hour dietary recall.

D.   Instruct the patient to reduce dietary sodium.

A.   Valsartan, Lisinopril

B.   Aliskiren, Valsartan

C.   Lisinopril, Eplerenone

D.   Diazoxide, Hydralazine

A.   Spironolactone, Warfarin, Alprazolam

B.   Warfarin, Ibuprofen, Alprazolam

C.   Spironolactone, Ibuprofen, Potassium chloride

D.   Warfarin, Alprazolam, Potassium chloride

A.   The risk for the side effect of cough is increased.

B.   Ibuprofen can potentiate the effect of losartan.

C.   Ibuprofen can lead to potential renal failure.

D.   Ibuprofen increases the risk for hypokalemia.

A.   "You may develop a nonproductive, dry cough from this medication." "The medication is contraindicated if you develop benign prostatic hypertrophy (BPH)."

B.   "A glass of wine a few times a week should not be a problem." "You may develop a nonproductive, dry cough from this medication."

C.   "Do not be concerned if you see the matrix of the capsule in your stool." "Be especially careful when changing position after your first dose of the medication."

D.   "The medication is contraindicated if you develop benign prostatic hypertrophy (BPH)." "A glass of wine a few times a week should not be a problem."

A.   Docusate sodium

B.   Morphine sulfate

C.   Spironolactone

D.   Aspirin

A.   "You will see the capsule shell in your stool, but don’t worry, the drug has been absorbed."

B.   "Some people get a feeling of chills for a few hours after the first dose."

C.   "You will get a headache the first time you take this medication."

D.   "Nausea and vomiting are common but can be helped by eating crackers."

A.   "If I have trouble sleeping, I should call the health care provider."

B.   "I cannot go out in the sun while on this therapy."

C.   "I should stop the drug if I have ringing in my ears."

D.   "If I develop a chronic cough, I should notify my health care provider."

A.   Serum sodium of 140 mEq/L

B.   Serum potassium of 3.8 mEq/L

C.   Cool, dry, pale extremities

D.   Blood pressure of 120/72 mm Hg

A.   Make certain the patient does not crush the pill.

B.   Measure hourly output.

C.   Administer with a full glass of water.

D.   Monitor blood pressure continuously.

A.   Angina pectoris

B.   Tachycardia

C.   Hypotension

D.   Subarachnoid hemorrhage

A.   "Only take this medication in the morning."

B.   "Sit on the side of the bed before getting up, and get up slowly."

C.   "Do not take the medication with food."

D.   "Take the medication with potassium supplements."

A.   A patient with a heart rate of 90 beats/min

B.   A patient with a potassium level of 3.4 mEq/L

C.   A patient with an elevated creatinine level

D.   A patient with constipation

A.   Notify the health care provider of this information.

B.   Monitor the patient for a toxic reaction to the drug.

C.   Administer a decreased dose of the medication.

D.   Administer an increased dose of the medication.